Fuminori Tatsumi

Comparison of the effects of three kinds of glucose‐lowering drugs on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open‐label, three‐arm, active control study

Tomoe Kinoshita, Masashi Shimoda, Koji Nakashima et al. · Journal of Diabetes Investigation · 2020 · 102 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes

Sumiko Hamamoto, Yukiko Kanda, Masashi Shimoda et al. · Diabetes Obesity and Metabolism · 2012 · 60 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus

Shinji Kamei, Masahiro Iwamoto, Miyuki Kameyama et al. · Journal of Diabetes Research · 2018 · 39 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus

Tomoe Kinoshita, Masashi Shimoda, Junpei Sanada et al. · Journal of Diabetes and its Complications · 2016 · 32 citations

Medicine, Neurology, Diabetology +13

Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus

Shuhei Nakanishi, Hidenori Hirukawa, Masashi Shimoda et al. · Diabetes Research and Clinical Practice · 2019 · 23 citations · Full text

Medicine, Internal Medicine, Nephrology +13